JFL Life Sciences Limited has announced a rights issue of equity shares, a move that offers existing shareholders the opportunity to increase their stake in the company. The Board of Directors made the decision on March 04, 2026, outlining the details of the offering.
The rights issue will be conducted in a 1:1 ratio, meaning that for every one equity share held, shareholders will be entitled to one additional share. The issue price has been set at Rs. 10 per share. This structure allows the company to raise capital by offering shares to its existing investors, who can then choose to exercise their rights and purchase the new shares.
The record date for the rights issue is set for March 10, 2026. This is the date by which an investor must be a registered shareholder of JFL Life Sciences to be eligible to participate in the rights issue. Shareholders who hold shares on or before this date will be entitled to receive the rights.
This corporate action, categorized under markets & economy and healthcare, indicates a strategic move by JFL Life Sciences. Such rights issues are often undertaken to raise capital for various corporate purposes, such as funding expansion, reducing debt, or investing in new projects. The rights issue provides a way for the company to raise funds while giving existing shareholders a chance to maintain their proportional ownership.
Tags associated with this announcement include: JFL Life Sciences Limited, rights issue, equity shares, stock market, corporate action, shareholder, investment, financial news, record date, and issue price.
Source: NSE News – Latest Announcements
About the Author
